Charles Morris

Chief Tech/Sci/R&D Officer at PRELUDE THERAPEUTICS INCORPORATED

61 year

Health Technology

Consumer Services

Profile

Charles Q.
Morris is currently a Member at The Royal College of Physicians and will be Chief Medical Officer at Prelude Therapeutics, Inc. starting in 2026.
Former positions include Vice President-Worldwide Clinical Research at Cephalon LLC; Chief Development Officer & Executive VP at ImmunoGen, Inc. from 2012 to 2016; Chief Medical Officer & Executive Vice President at Allos Therapeutics, Inc. from 2010 to 2012; Chief Medical Officer at Radius Health, Inc. from 2018 to 2020; Vice President-Clinical Development Projects at AstraZeneca Pharmaceuticals LP; Chief Development Officer at Akamis Bio Ltd. from 2016 to 2018; Chief Medical Officer at Celyad Oncology SA from 2021 to 2023; and Chief Medical Officer at LAVA Therapeutics NV from 2023 to 2025.
Education includes undergraduate studies at the University of Sheffield Medical School.

Charles Morris active positions

Companies	Position	Start
PRELUDE THERAPEUTICS INCORPORATED	Chief Tech/Sci/R&D Officer	20/04/2026
The Royal College of Physicians The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	09/07/2010

All active positions of Charles Morris

Former positions of Charles Morris

Companies	Position	End
LAVA THERAPEUTICS	Chief Tech/Sci/R&D Officer	01/10/2025
CELYAD ONCOLOGY SA	Chief Tech/Sci/R&D Officer	01/01/2023
RADIUS HEALTH, INC.	Chief Tech/Sci/R&D Officer	15/12/2020
Akamis Bio Ltd. Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies	Corporate Officer/Principal	01/09/2018
IMMUNOGEN, INC.	Corporate Officer/Principal	02/09/2016

See the detail of Charles Morris's experience

Training of Charles Morris

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles Morris's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products	Health Technology
ImmunoGen, Inc. ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics	Health Technology
Allos Therapeutics, Inc. Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets anti-cancer therapeutics	Health Technology
Radius Health, Inc. Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics	Health Technology
AstraZeneca Pharmaceuticals LP AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals	Health Technology
The Royal College of Physicians The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Celyad Oncology SA Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products	Health Technology
Akamis Bio Ltd. Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies	Health Technology
Prelude Therapeutics, Inc. Prelude Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines targeting chromatin function to treat cancer and rare diseases	Health Technology
LAVA Therapeutics NV LAVA Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops antibodies for the treatment of cancer	Health Technology
University of Sheffield Medical School University of Sheffield Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services